Skip to main content
Miracles Jar
← All claims
medicalGeneva University Hospitals (HUG), Geneva, Switzerland·Transplant 2018; antiretroviral therapy stopped November 2021; remission documented through 2024·4 min read

The Geneva Patient: HIV Remission Without the Protective Mutation

A man known as "Romuald," the Geneva patient, has sustained HIV remission off all antiretroviral therapy for roughly three years after a stem-cell transplant from a donor lacking the CCR5-delta32 mutation that every prior cure-class case had relied on. His cells remain biologically susceptible to HIV, yet the virus stays undetectable — and researchers cannot fully explain why.

Our verdict is hidden below until you lock in a guess or choose to skip.

A man known as "Romuald," the Geneva patient, has sustained HIV remission off all antiretroviral therapy for roughly three years after a stem-cell transplant from a donor lacking the CCR5-delta32 mutation that every prior cure-class case had relied on. His cells remain biologically susceptible to HIV, yet the virus stays undetectable — and researchers cannot fully explain why.

A fuller write-up of the documentation and analysis is in progress.

#HIV#stem-cell transplant#CCR5#remission#unexplained medical#Nature Medicine#immunology#Geneva patient

Sources

Tagged by proximity to the event. Primary sources are direct or contemporaneous; tertiary are downstream retellings.

  1. 1.
    Primaryacademic

    Asier Sáez-Cirión, Alexandra Calmy, et al., "Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells", Nature Medicine, 2024

    Peer-reviewed primary report. Confirms 53-year-old male patient (study ID IciS-34), >30 years living with HIV-1, allo-HSCT for extramedullary myeloid tumor, unrelated 9/10 HLA-matched donor with no CCR5Δ32 mutation, and undetectable viral load for 32 months after ART interruption. States control mechanisms remain unclear; flags allogeneic immunity and ruxolitinib as candidate factors.

  2. 2.
    Primaryother

    Institut Pasteur, "First sustained remission of HIV infection following a bone marrow transplant in absence of protective mutation", Institut Pasteur, 2024

    Official institutional press release (used here as a primary institutional source, not a religious document). Confirms patient nickname 'Romuald,' wild-type CCR5 donor, remission nearly three years after stopping ART, the three proposed mechanisms, leads Calmy (HUG/Univ. Geneva) and Sáez-Cirión (Institut Pasteur), and that seven individuals worldwide are considered cured/in long-term remission after such transplants. Publication date September 2, 2024.

  3. 3.
    Secondarynews

    "Study: First sustained remission of HIV infection following a bone marrow transplant in absence of protective mutation", Medical Xpress, 2024

    Science-news coverage corroborating the same facts: 'Romuald, the Geneva patient,' wild-type CCR5 donor leaving his cells susceptible to HIV, nearly three years off ART, and the three candidate mechanisms. Contrasts with Berlin/London cases where CCR5-delta32 was decisive.

Related claims